GSK Inks Deal With Futura To License, Distribute OTC Erection Gel
This article was originally published in The Tan Sheet
Executive Summary
Futura Medical expects that its MED2002 topical gel will become the world's first over-the-counter pharmaceutical treatment option for men with erectile dysfunction without the side effects associated with ED drugs such as Pfizer's Viagra (sildenafil citrate), the Surrey, UK-based company announced July 4
You may also be interested in...
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Chattem’s Financing Strategy Keeps Door Open For Acquisitions
Chattem remains in the hunt for acquisitions because its preferred financing strategy continues to be attractive even with lending activity slowed worldwide, according to President and Chief Operating Officer Bob Bosworth